Syros Pharmaceuticals Inc...
(SYRS)
undefined
undefined%
At close: undefined
0.25
3.62%
After-hours Jan 03, 2025, 05:56 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Revenue | 9.94M | 14.88M | 23.49M | 15.09M | 1.98M | 2.05M | 1.10M | 317.00K | 317.00K | n/a | n/a |
| Cost of Revenue | 2.25M | 2.97M | n/a | n/a | n/a | n/a | 1.53M | n/a | 602.00K | n/a | n/a |
| Gross Profit | 7.68M | 11.91M | 23.49M | 15.09M | 1.98M | 2.05M | -426.00K | 317.00K | -285.00K | n/a | n/a |
| Operating Income | -128.99M | -135.87M | -99.42M | -82.30M | -77.74M | -64.30M | -54.69M | -47.96M | -29.82M | -13.44M | -8.63M |
| Interest Income | 6.82M | 2.13M | 87.00K | 426.00K | 2.30M | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -164.57M | -94.65M | -86.56M | -84.04M | -75.44M | -62.28M | -54.01M | -47.74M | -29.82M | -13.43M | -8.66M |
| Net Income | -164.57M | -49.30M | -90.47M | -85.83M | -75.44M | -62.28M | -54.01M | -47.74M | -29.82M | -13.43M | -9.26M |
| Selling & General & Admin | 28.28M | 29.30M | 23.04M | 21.32M | 21.48M | 16.16M | 13.89M | 10.46M | 5.73M | 2.51M | 2.37M |
| Research & Development | 108.15M | 111.94M | 99.87M | 76.06M | 58.24M | 50.18M | 41.90M | 37.82M | 24.41M | 10.92M | 6.27M |
| Other Expenses | n/a | -9.51M | n/a | n/a | 2.30M | 2.02M | 676.00K | 220.00K | 2.00K | 4.00K | n/a |
| Operating Expenses | 138.92M | 141.24M | 122.91M | 97.39M | 79.72M | 66.35M | 55.79M | 48.28M | 30.14M | 13.44M | 8.66M |
| Interest Expense | 5.13M | 4.13M | 3.91M | 1.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 138.92M | 141.24M | 122.91M | 97.39M | 79.72M | 66.35M | 55.79M | 48.28M | 30.14M | 13.44M | 8.66M |
| Income Tax | n/a | -45.35M | 3.91M | 1.79M | 2.55M | 2.02M | -1.53M | n/a | n/a | n/a | 594.00K |
| Shares Outstanding (Basic) | 28.33M | 12.63M | 6.25M | 4.61M | 4.02M | 3.27M | 2.54M | 1.27M | 247.56K | 247.56K | 109.62K |
| Shares Outstanding (Diluted) | 28.33M | 12.63M | 6.25M | 4.61M | 4.02M | 3.27M | 2.54M | 1.27M | 247.56K | 247.56K | 109.62K |
| EPS (Basic) | -5.81 | -3.9 | -14.47 | -18.64 | -18.76 | -19.07 | -21.26 | -37.6 | -120.45 | -54.25 | -84.47 |
| EPS (Diluted) | -5.81 | -3.9 | -14.47 | -18.64 | -18.76 | -19.07 | -21.26 | -37.6 | -120.45 | -54.25 | -84.47 |
| EBITDA | -157.19M | -87.55M | -79.63M | -79.21M | -72.72M | -60.67M | -53.16M | -46.69M | -29.22M | -13.18M | -8.46M |
| Depreciation & Amortization | 2.25M | 2.97M | 3.02M | 3.04M | 2.72M | 1.60M | 1.53M | 1.27M | 602.00K | 258.00K | 170.00K |